Larimar Therapeutics (LRMR) 8-K/A Other Events

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on FormS-8 (Nos.333-196900,333-204931,333-210216,333-216602,333-223561,333-230291,333-234579,333-236917, and 333-228326) and FormS-3 (Nos.333-219834 and333-228328) of Larimar Therapeutics, Inc. of our report dated March 6, 2020 relating to the financial statements of Chondrial Therapeutics, Inc., which appears in this Current Report on Form8-K/A.

/s/ PricewaterhouseCoopers LLP

Philadelphia, Pennsylvania

June 26, 2020